Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (2732)	1/26/2011 12:45:27 PM
From: Biomaven	Read Replies (1) of 3027

Let's assume that Teva infringed MNTA IP when determining the appropriate temperatures, PH, timing, etc. But what if in the production process all they do is simply measure those factors? Are they still infringing? It's certainly the case that Sanofi doesn't infringe in their production process, so it seems to that it is possible to manufacture the drug without infringing. Note there is also the statutory exemption from patent infringement for pharmaceutical R&D potentially in play here: buildingipvalue.com Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next